Compounds > astragaloside a
Page last updated: 2024-09-03

astragaloside a and Endomyocardial Fibrosis

astragaloside a has been researched along with Endomyocardial Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, Q; Liu, YH; Lu, J; Lu, XC; Ma, YT; Tang, YQ; Wang, QY; Wu, Y; Zhou, Y1
Li, SJ; Yang, YZ; Zhang, ZC1

Other Studies

2 other study(ies) available for astragaloside a and Endomyocardial Fibrosis

ArticleYear
AstragalosideⅣ against cardiac fibrosis by inhibiting TRPM7 channel.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Jul-01, Volume: 30

    Topics: Animals; Cell Differentiation; Cell Hypoxia; Cell Proliferation; Endomyocardial Fibrosis; Fibroblasts; Heart; Isoproterenol; Male; Mice; NIH 3T3 Cells; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes; TRPM Cation Channels; Up-Regulation

2017
[Effect of astragaloside on myocardial fibrosis in chronic myocarditis].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2007, Volume: 27, Issue:8

    Topics: Animals; Blotting, Western; Chronic Disease; Coxsackievirus Infections; Drugs, Chinese Herbal; Endomyocardial Fibrosis; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 14; Mice; Mice, Inbred BALB C; Myocarditis; Random Allocation; Saponins; Transforming Growth Factor beta; Triterpenes

2007